PIPERACILLINE/TAZOBACTAM EG 4 g/500 mg, powder for solution for infusion bottle, 50 ml
Active ingredients: Piperacillin, Piperacillin sodium, Tazobactam, Tazobactam sodium
Commercialized according to BDPMDispensing in France: Prescription only
Powder for solution for infusionbottle, 50 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PIPERACILLINE/TAZOBACTAM EG 4 g/500 mg, poudre pour solution pour perfusion
- Pharmaceutical form
- poudre pour solution pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 50 ml
- Marketing authorisation holder
- EG LABO - LABORATOIRES EUROGENERICS
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Sept 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64130978CIP73024427CIP133400930244272Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIPÉRACILLINE SODIQUEpoudre | — | SA |
| TAZOBACTAMpoudre | 500 mg · un flacon | FT |
| TAZOBACTAM SODIQUEpoudre | — | SA |
| PIPÉRACILLINEpoudre | 4 g · un flacon | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.